Sanofi AB
Sanofi AB, a prominent subsidiary of the global healthcare leader Sanofi, is headquartered in Sweden (SE) and operates extensively across Europe and beyond. Founded in 2004, Sanofi AB has established itself within the pharmaceutical industry, focusing on innovative solutions in areas such as diabetes, oncology, and rare diseases.
The company is renowned for its commitment to research and development, delivering unique products that address unmet medical needs. Sanofi AB's portfolio includes cutting-edge biologics and vaccines, which have significantly contributed to its strong market position. With a dedication to improving patient outcomes, Sanofi AB continues to achieve notable milestones, reinforcing its reputation as a key player in the healthcare sector.
+60 vs industry average
Sanofi AB’s score of 100 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sanofi AB?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Sanofi AB yet.
Sanofi AB's reported carbon emissions
Sanofi AB, headquartered in Sweden (SE), currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Sanofi, it inherits its climate commitments and emissions data from its parent company.
Sanofi has made significant strides in addressing climate change through various initiatives. The company has set science-based targets (SBTi) aimed at reducing greenhouse gas emissions across its operations. These targets are cascaded from the parent organization, ensuring alignment with industry standards for sustainability.
While specific reduction targets and achievements for Sanofi AB are not detailed, the overarching commitments from Sanofi include participation in initiatives such as the Carbon Disclosure Project (CDP) and RE100, which focus on transparency and transitioning to renewable energy sources.
Sanofi's climate strategy reflects a commitment to reducing Scope 1, 2, and 3 emissions, although specific figures for these scopes are not provided. The company is actively working towards enhancing its sustainability practices and reducing its overall carbon footprint in line with global climate goals.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sanofi AB’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Sanofi AB yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project